James ND - Search Results

1

Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy.

Cooke PW, James ND, Ganesan R, Burton A, Young LS, Wallace DM. Cooke PW, et al. Among authors: james nd. BJU Int. 2000 May;85(7):829-35. doi: 10.1046/j.1464-410x.2000.00612.x. BJU Int. 2000. PMID: 10792161 Clinical Trial.

2

A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.

Hussain SA, Moffitt DD, Glaholm JG, Peake D, Wallace DM, James ND. Hussain SA, et al. Among authors: james nd. Ann Oncol. 2001 Jul;12(7):929-35. doi: 10.1023/a:1011133820532. Ann Oncol. 2001. PMID: 11521797 Free article. Clinical Trial.

3

Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder.

Hussain SA, Ganesan R, Hiller L, Murray PG, el-Magraby MM, Young L, James ND. Hussain SA, et al. Among authors: james nd. Br J Cancer. 2003 Feb 24;88(4):586-92. doi: 10.1038/sj.bjc.6600765. Br J Cancer. 2003. PMID: 12592374 Free PMC article.

4

BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder.

Hussain SA, Ganesan R, Hiller L, Cooke PW, Murray P, Young LS, James ND. Hussain SA, et al. Among authors: james nd. Oncol Rep. 2003 May-Jun;10(3):571-6. Oncol Rep. 2003. PMID: 12684626

5

CD40 expression in bladder cancer.

Cooke PW, James ND, Ganesan R, Wallace M, Burton A, Young LS. Cooke PW, et al. Among authors: james nd. J Pathol. 1999 May;188(1):38-43. doi: 10.1002/(SICI)1096-9896(199905)188:1<38::AID-PATH315>3.0.CO;2-B. J Pathol. 1999. PMID: 10398138

6

Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancer.

Cooke PW, Dunn JA, Latief T, Bathers S, James ND, Wallace DM. Cooke PW, et al. Among authors: james nd. Eur Urol. 2000 Sep;38(3):279-86. doi: 10.1159/000020294. Eur Urol. 2000. PMID: 10940701 Clinical Trial.

7

Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer.

Hussain SA, Stocken DD, Peake DR, Glaholm JG, Zarkar A, Wallace DM, James ND. Hussain SA, et al. Among authors: james nd. Br J Cancer. 2004 Jun 1;90(11):2106-11. doi: 10.1038/sj.bjc.6601852. Br J Cancer. 2004. PMID: 15150587 Free PMC article. Clinical Trial.

8

CD40 expression in prostate cancer: a potential diagnostic and therapeutic molecule.

Palmer DH, Hussain SA, Ganesan R, Cooke PW, Wallace DM, Young LS, James ND. Palmer DH, et al. Among authors: james nd. Oncol Rep. 2004 Oct;12(4):679-82. doi: 10.3892/or.12.4.679. Oncol Rep. 2004. PMID: 15375484

9

Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.

Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, James ND, Spooner D, Poole CJ, Rea DW, Palmer DH. Hussain SA, et al. Among authors: james nd. Br J Cancer. 2007 Jan 15;96(1):104-9. doi: 10.1038/sj.bjc.6603530. Br J Cancer. 2007. PMID: 17213826 Free PMC article.

10

Combining gene and immunotherapy for prostate cancer.

Young JG, Green NK, Mautner V, Searle PF, Young LS, James ND. Young JG, et al. Among authors: james nd. Prostate Cancer Prostatic Dis. 2008;11(2):187-93. doi: 10.1038/sj.pcan.4501008. Epub 2007 Aug 28. Prostate Cancer Prostatic Dis. 2008. PMID: 17726452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page